Advanced Enzyme Technologies Limited has announced a conference call for analysts and investors to discuss its financial results for the quarter and year ended March 31, 2026. The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated to the stock exchanges on May 05, 2026 by Company Secretary and Head – Legal, Sanjay Basantani.

Conference Call Details

The conference call is scheduled for Tuesday, May 12, 2026, at 09:00 hours IST. The following table summarises the key details of the event:

Participants are advised to dial in at least 5–10 minutes prior to the scheduled time to ensure timely connection. Access numbers for other countries are available on request, and participants may also pre-register via the provided registration link to avoid wait time.

Management Representation

The company's management team representing Advanced Enzyme Technologies on the call will include:

• Mr. Mukund Kabra – Whole-time Director
• Mr. Beni Prasad Rauka – Chief Financial Officer

Investor Relations Contact

For further information or RSVP, investors and analysts may reach out to the company's Investor Relations representative:

The information pertaining to the conference call has also been uploaded on the company's official website. Advanced Enzyme Technologies is headquartered at 5th Floor, 'A' Wing, Sun Magnetica, Louiswadi, Thane (W) – 400 604, and can be reached at +91 22 41703200.

advanced enzyme tech has scheduled a meeting of its Board of Directors for Saturday, May 9, 2026. The meeting will be held to consider and approve the Annual Financial Statements, both standalone and consolidated, for the financial year ended March 31, 2026, along with the results of the fourth quarter.

Agenda Items

The board will deliberate on several key matters during the meeting:

• To consider and approve Annual Financial Statements (Standalone & Consolidated) for the financial year ended March 31, 2026 along with Q4 results
• To consider and recommend Final dividend, if any, for the financial year ended March 31, 2026
• To consider and declare Interim dividend, if any, for the financial year ended March 31, 2027

Trading Window Closure

In compliance with regulatory requirements, the company has informed that the Trading Window for dealing in the securities of the company will continue to remain closed up to May 11, 2026. This closure follows the earlier intimation dated March 26, 2026.

Company Details

The intimation has been uploaded on the company's website at www.advancedenzymes.com and is also available on the websites of BSE Limited ( www.bseindia.com ) and National Stock Exchange of India Ltd. ( www.nseindia.com ).